KR20050055628A - 1-페닐알킬-피페라진 - Google Patents
1-페닐알킬-피페라진 Download PDFInfo
- Publication number
- KR20050055628A KR20050055628A KR1020047020369A KR20047020369A KR20050055628A KR 20050055628 A KR20050055628 A KR 20050055628A KR 1020047020369 A KR1020047020369 A KR 1020047020369A KR 20047020369 A KR20047020369 A KR 20047020369A KR 20050055628 A KR20050055628 A KR 20050055628A
- Authority
- KR
- South Korea
- Prior art keywords
- piperazine
- compound
- group
- dihydro
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/108—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2002A001327 | 2002-06-14 | ||
IT2002MI001327A ITMI20021327A1 (it) | 2002-06-14 | 2002-06-14 | Nuove ossialchilpiperazine |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20050055628A true KR20050055628A (ko) | 2005-06-13 |
Family
ID=29727276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020047020369A KR20050055628A (ko) | 2002-06-14 | 2003-06-16 | 1-페닐알킬-피페라진 |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1549627A1 (ja) |
JP (1) | JP2006502102A (ja) |
KR (1) | KR20050055628A (ja) |
CN (1) | CN1659155A (ja) |
AU (1) | AU2003246434A1 (ja) |
BR (1) | BR0311804A (ja) |
CA (1) | CA2489449A1 (ja) |
EA (1) | EA200500024A1 (ja) |
HR (1) | HRP20050033A2 (ja) |
IL (1) | IL165569A0 (ja) |
IT (1) | ITMI20021327A1 (ja) |
MX (1) | MXPA04012489A (ja) |
NO (1) | NO20050147L (ja) |
NZ (1) | NZ537470A (ja) |
PL (1) | PL372702A1 (ja) |
RS (1) | RS109004A (ja) |
TW (1) | TW200406394A (ja) |
WO (1) | WO2003106443A1 (ja) |
ZA (1) | ZA200500317B (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7071197B2 (en) * | 2002-06-14 | 2006-07-04 | Recordati S.A. | N,N-disubstituted diazocycloalkanes |
US7365076B2 (en) * | 2003-10-14 | 2008-04-29 | Wyeth | Substituted aryl cycloalkanol derivatives and methods of their use |
KR101468553B1 (ko) | 2007-05-14 | 2014-12-09 | 에스케이바이오팜 주식회사 | 신규 카바모일옥시 아릴알칸노일 아릴피페라진계 화합물,이를 함유하는 약제학적 조성물 및 상기 화합물 투여에의한 통증, 불안증 및 우울증 치료 방법 |
WO2015132733A1 (en) * | 2014-03-05 | 2015-09-11 | Universita' Degli Studi Di Pavia | Use of arylalkanolamines as sigma-1 receptor antagonists |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5826348B2 (ja) * | 1974-07-01 | 1983-06-02 | 住友化学工業株式会社 | 新規ベンゾイソキサゾ−ル誘導体の製造法 |
FR2527605A1 (fr) * | 1982-05-25 | 1983-12-02 | Fordonal Sa | Derives de piperazine, procede de fabrication et medicaments en resultant |
GB9021535D0 (en) * | 1990-10-03 | 1990-11-14 | Wyeth John & Brother Ltd | Piperazine derivatives |
GB9022820D0 (en) * | 1990-10-19 | 1990-12-05 | Wyeth John & Brother Ltd | Piperazine derivatives |
GB9125900D0 (en) * | 1991-12-05 | 1992-02-05 | Wyeth John & Brother Ltd | Piperazine derivatives |
JP3523887B2 (ja) * | 1992-03-09 | 2004-04-26 | 武田薬品工業株式会社 | 縮合複素環ケトン誘導体、その製造法、中間体および剤 |
NZ250609A (en) * | 1992-12-28 | 1995-07-26 | Sankyo Co | Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments |
GB9300195D0 (en) * | 1993-01-06 | 1993-03-03 | Wyeth John & Brother Ltd | Piperazine derivatives |
GB9419024D0 (en) * | 1994-09-21 | 1994-11-09 | Wyeth John & Brother Ltd | Bicyclic carboxamides |
GB9514384D0 (en) * | 1995-07-13 | 1995-09-13 | American Home Prod | Medical treatment |
UA66370C2 (en) * | 1997-12-16 | 2004-05-17 | Lilly Co Eli | Arylpiperazines having activity to setotonin 1 receptors |
-
2002
- 2002-06-14 IT IT2002MI001327A patent/ITMI20021327A1/it unknown
-
2003
- 2003-06-16 TW TW092116294A patent/TW200406394A/zh unknown
- 2003-06-16 PL PL03372702A patent/PL372702A1/xx unknown
- 2003-06-16 RS YUP-1090/04A patent/RS109004A/sr unknown
- 2003-06-16 MX MXPA04012489A patent/MXPA04012489A/es unknown
- 2003-06-16 KR KR1020047020369A patent/KR20050055628A/ko not_active Application Discontinuation
- 2003-06-16 NZ NZ537470A patent/NZ537470A/en unknown
- 2003-06-16 CA CA002489449A patent/CA2489449A1/en not_active Abandoned
- 2003-06-16 CN CN038136759A patent/CN1659155A/zh active Pending
- 2003-06-16 EP EP03759960A patent/EP1549627A1/en not_active Withdrawn
- 2003-06-16 BR BR0311804-5A patent/BR0311804A/pt not_active IP Right Cessation
- 2003-06-16 WO PCT/EP2003/006289 patent/WO2003106443A1/en not_active Application Discontinuation
- 2003-06-16 EA EA200500024A patent/EA200500024A1/ru unknown
- 2003-06-16 JP JP2004513275A patent/JP2006502102A/ja active Pending
- 2003-06-16 AU AU2003246434A patent/AU2003246434A1/en not_active Abandoned
-
2004
- 2004-12-06 IL IL16556904A patent/IL165569A0/xx unknown
-
2005
- 2005-01-11 NO NO20050147A patent/NO20050147L/no not_active Application Discontinuation
- 2005-01-12 HR HR20050033A patent/HRP20050033A2/xx not_active Application Discontinuation
- 2005-01-13 ZA ZA200500317A patent/ZA200500317B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NO20050147L (no) | 2005-03-14 |
ZA200500317B (en) | 2006-11-29 |
WO2003106443A1 (en) | 2003-12-24 |
HRP20050033A2 (en) | 2006-11-30 |
ITMI20021327A1 (it) | 2003-12-15 |
MXPA04012489A (es) | 2005-06-08 |
CN1659155A (zh) | 2005-08-24 |
AU2003246434A1 (en) | 2003-12-31 |
EA200500024A1 (ru) | 2005-06-30 |
PL372702A1 (en) | 2005-07-25 |
NZ537470A (en) | 2006-06-30 |
JP2006502102A (ja) | 2006-01-19 |
NO20050147D0 (no) | 2005-01-11 |
EP1549627A1 (en) | 2005-07-06 |
RS109004A (en) | 2007-02-05 |
IL165569A0 (en) | 2006-01-15 |
TW200406394A (en) | 2004-05-01 |
BR0311804A (pt) | 2005-03-29 |
CA2489449A1 (en) | 2003-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7071197B2 (en) | N,N-disubstituted diazocycloalkanes | |
JP6928629B2 (ja) | Cns疾患を治療するための縮合ジヒドロ−4h−ピラゾロ[5,1−c][1,4]オキサジニル化合物およびアナログ | |
RU2199533C2 (ru) | Производные 1-(n-фениламиноалкил)пиперазина и фармацевтическая композиция | |
CA3105681A1 (en) | Pyridazinone derivative | |
EP3303331A1 (en) | Muscarinic m1 receptor positive allosteric modulators | |
US9598434B2 (en) | Benzazepine compound | |
AU2017327304B2 (en) | Use of morphinan derivative for therapeutic treatment of opioid δ receptor agonist-related disease | |
JP2001512110A (ja) | 1,4−ジ置換ピペラジン | |
KR20050055628A (ko) | 1-페닐알킬-피페라진 | |
US6399614B1 (en) | 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring | |
US20040072839A1 (en) | 1-Phenylalkylpiperazines | |
US20060148821A1 (en) | N,N-disubstituted diazocycloalkanes | |
WO2003106421A2 (en) | Phenylalkylamines and pyridylalkylamines | |
US20070270436A1 (en) | Novel amino- and imino-alkylpiperazines | |
US20040058962A1 (en) | Phenylalkylamines and pyridylalkylamines | |
JP2007186422A (ja) | アリールスルフィド誘導体 | |
US20020193383A1 (en) | 1-(N-phenylalkylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring | |
KR20050044867A (ko) | 세로토닌계 장애에 기인한 cns 장애 치료에 유용한n,n-이치환 디아조시클로알칸 | |
EP3196200B1 (en) | 2-aminothiazole derivatives or salt thereof as muscarinic m3 ligands for the treatment of bladder diseases | |
FR2717174A1 (fr) | Utilisation de pipéridinoéthyl esters de l'acide 4-amino-5-chloro-2-méthoxybenzoïque comme 5-HT4 agonistes. | |
JP2006503859A (ja) | 受容体拮抗薬としてのアザ二環式スピロエーテル誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |